InsiderChief Executive Officer

Stephane Bancel Insider Trading Activity

Every SEC Form 4 transaction reported by Stephane Bancel, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Stephane Bancel buying or selling?

Stephane Bancel reported 1 open-market buys ($5.0M) and 266 sells ($1.2B) across 267 Form 4 filings at 1 company — a net selling position of $1.2B.

Source: SEC EDGAR Form 4

What stands out

  • All 267 of Stephane Bancel's Form 4 filings are for one company, Moderna, Inc. (MRNA).
  • The most recent Form 4 was accepted on Aug 7, 2026 (2 months ago).
  • In the last 12 months: no open-market purchases and 1 sale ($28.7M).
  • The largest open-market sale in the last 12 months was $28.7M of Moderna, Inc. (MRNA) on Aug 7, 2026. SEC ↗

Key Statistics (as of Aug 7, 2026)

Total Form 4 filings
267
SEC EDGAR
Companies
1
Buys (1)
$5.0M
Sells (266)
$1.2B

Insider sentiment

Net selling

Net insider flow of $1.2B in net selling, filed between Nov 5, 2019 – Aug 7, 2026.

Companies Stephane Bancel files for

#CompanyForm 4 filings
1MRNAModerna, Inc.267

Recent Stephane Bancel transactions

DateTickerRoleTypeSharesValueFiling
Aug 7, 2026MRNAChief Executive OfficerSale499.2K$28.7MSEC ↗
Mar 4, 2025MRNAChief Executive OfficerPurchase160.3K$5.0MSEC ↗
Feb 16, 2024MRNAChief Executive OfficerSale26.4K$2.3MSEC ↗
Jun 30, 2023MRNAChief Executive OfficerSale27.2K$3.3MSEC ↗
Jun 23, 2023MRNAChief Executive OfficerSale80.0K$9.7MSEC ↗
Jun 16, 2023MRNAChief Executive OfficerSale80.0K$10.2MSEC ↗
Jun 9, 2023MRNAChief Executive OfficerSale80.0K$10.0MSEC ↗
Jun 2, 2023MRNAChief Executive OfficerSale80.0K$10.2MSEC ↗
May 26, 2023MRNAChief Executive OfficerSale80.0K$10.4MSEC ↗
May 19, 2023MRNAChief Executive OfficerSale80.0K$10.0MSEC ↗
May 12, 2023MRNAChief Executive OfficerSale80.0K$10.4MSEC ↗
May 5, 2023MRNAChief Executive OfficerSale80.0K$10.7MSEC ↗
Apr 28, 2023MRNAChief Executive OfficerSale80.0K$10.5MSEC ↗
Apr 21, 2023MRNAChief Executive OfficerSale80.0K$11.4MSEC ↗
Apr 14, 2023MRNAChief Executive OfficerSale80.0K$12.7MSEC ↗
Apr 7, 2023MRNAChief Executive OfficerSale80.0K$12.5MSEC ↗
Mar 31, 2023MRNAChief Executive OfficerSale80.0K$11.9MSEC ↗
Mar 24, 2023MRNAChief Executive OfficerSale80.0K$12.0MSEC ↗
Mar 17, 2023MRNAChief Executive OfficerSale80.0K$12.0MSEC ↗
Mar 10, 2023MRNAChief Executive OfficerSale80.0K$11.2MSEC ↗
Mar 3, 2023MRNAChief Executive OfficerSale80.0K$10.9MSEC ↗
Feb 24, 2023MRNAChief Executive OfficerSale80.0K$12.2MSEC ↗
Feb 17, 2023MRNAChief Executive OfficerSale80.0K$13.9MSEC ↗
Feb 10, 2023MRNAChief Executive OfficerSale80.0K$13.3MSEC ↗
Feb 3, 2023MRNAChief Executive OfficerSale80.0K$13.8MSEC ↗

Showing the 25 most recent filings of 267. Screen every filing.

Stephane Bancel insider trading FAQ

Is Stephane Bancel buying or selling?

Across 267 SEC Form 4 filings, Stephane Bancel reported 1 open-market purchases totaling $5.0M and 266 sales totaling $1.2B — a net selling position of $1.2B.

Which companies does Stephane Bancel file Form 4s for?

Stephane Bancel has reported insider transactions at 1 company, most often Moderna, Inc. (MRNA).

How far back does Stephane Bancel's filing history go?

Trabud holds Stephane Bancel's SEC Form 4 filings from Nov 5, 2019 – Aug 7, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Stephane Bancel's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Stephane Bancel and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener